Plasma concentrations of 6-keto-prostaglandin f1α in patients with hypertension, cerebrovascular disease or Takayasu's arteritis
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 25 (1-2) , 71-79
- https://doi.org/10.1016/0049-3848(82)90215-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Plasma concentrations of thromboxane B2 in patients with hypertension or cerebrovascular diseaseProstaglandins and Medicine, 1981
- The Effect of Clinical Prostacyclin Infusions in Advanced Arterial Disease on Platelet Function and Plasma 6-keto PGF1αLevelsBritish Journal of Haematology, 1981
- Enhanced 6-oxo-PGF1α levels in plasma during hemodialysisProstaglandins and Medicine, 1980
- PROSTACYCLIN AND THROMBOXANE METABOLITES IN DIABETESThe Lancet, 1979
- A sensitive radioimmunoassay for 6-keto-prostaglandin F1α: preliminary observations on circulating concentrationsProstaglandins and Medicine, 1978
- A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- COMPUTER ANALYSIS OF RADIOLIGAND ASSAY AND RADIOIMMUNOASSAY DATAActa Endocrinologica, 1970
- Approximate Significance Levels of the Behrens-Fisher TestBiometrics, 1964